Hematology Analyzer Market
Report Highlights
The global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028, at a compound annual growth rate (CAGR) of 5.7% from 2023 through 2028.
Report Includes
- 19 data tables and 45 additional tables
- An overview of global market outlook for hematology analyzers
- Analyses of global market trends, with data from 2020-2023 and projections of compound annual growth rates (CAGRs) through 2028
- Identification of market trends, issues and forecast impacting the global hematology analyzers market and quantification of the market based on product/service, end user, and region
- Discussion on market drivers such as growing incidence of blood disorders, increased preference for automated hematology instruments, and technological advancements in hematology analyzers
- Discussion on recent advancements and innovations available in the market
- Comprehensive company profiles of key players in the market, including Abbott, Boule Diagnostics AB, EKF Diagnostics Holdings Plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corp., and Nihon Kohden Corp.
Report Scope
The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2022 |
| Forecast period considered | 2023-2028 |
| Base year market size | $3.8 billion |
| Market size forecast | $5.3 billion |
| Growth rate | CAGR of 5.7% for the forecast period of 2023-2028 |
| Units considered | $ Millions |
| Segments covered | product/service, end user, and region |
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World |
| Countries covered | U.S., Canada, Germany, U.K., France, Italy, China, Japan, and India |
| Key Market Drivers |
|
| Companies studied |
|